Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody–Associated Vasculitides: A French Nationwide Study of Ninety‐Two PatientsÉtienne Crickx, Thierry Martin, Alexandre Mania et al.|Arthritis & Rheumatology|2015Cited by 69
Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥65 years with immune thrombocytopeniaMarc Michel, Xuena Wang, Jeffrey S. Wasser et al.|Annals of Hematology|2015Cited by 30
Safety and Efficacy Of Rituximab In adult’s Immune Thrombocytopenia (ITP) : Results After One-Year Of Follow-Up In 252 Patients From The Prospective French ITP-Ritux RegistryMehdi Khellaf, Bertrand Godeau, Olivier Fain et al.|Blood|2013Cited by 4